Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated rats

Journal of the American College of Surgeons

Volumn 189, Issue 4, 1999, Pages 374-379

  Kimmings, Anne N ^a   Van Deventer, Sander J H ^a   Obertop, Huug ^a   Gouma, Dirk J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CYTOKINE; ENDOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTOXEMIA; MALE; MONONUCLEAR CELL; NONHUMAN; OBSTRUCTIVE JAUNDICE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT; SURGICAL MORTALITY;

ANIMALS; BILE DUCTS; CHOLESTASIS; ENDOTOXEMIA; ESCHERICHIA COLI; INFLAMMATION; LIGATION; MALE; MEMBRANE PROTEINS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 0032885053     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00164-7     Document Type: Article

References (25)

1. Trede M, Schwall G. The complications of pancreatectomy. Ann Surg 1988;207:39-41.
2. Diamond T, Rowlands BJ. Endotoxaemia in obstructive jaundice. HPB Surg 1991;4:81-94.
3. Kimmings AN, van Deventer SJH, Obertop H, et al. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg 1995;181:567-581.
4. Gouma DJ, Coelho JCU, Schlegel JF, et al. The effect of preoperative internal and external biliary drainage on mortality of jaundiced rats. Arch Surg 1987;122:731-734.
5. Ding JW, Andersson R, Soltez V, et al. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur Surg Res 1993;25:11-19.
6. Pain JA. Reticulo-endothelial function in obstructive jaundice. Br J Surg 1987;74:1091-1094.
7. Greve JW, Maessen JG, Tiebosch T, et al. Prevention of postoperative complications in jaundiced rats. Ann Surg 1991;212:221-227.
8. Lai ECS, Mok FPT, Fan ST, et al. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994;81:1195-1198.
9. Karsten TM, Allema JH, Reinders M, et al. Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: a retrospective analysis of 241 consecutive patients. Eur J Surg 1996;162:881-888.
10. Weiss J, Elsbach P, Olsson I, et al. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978;253:2664-2672.
11. Marra MN, Wilde CG, Griffith JE, et al. Bactericidal/permeability increasing protein has endotoxin neutralizing ability. J Immunol 1990;144:662-666.
12. Marra MN, Wilde CG, Collins MS, et al. The role of bactericidal/permeability increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol 1992;148:532-537.
13. 2-terminal fragment carries all the antibacterial activities of the human neutrophil 60 kDa bactericidal/permeability increasing protein. J Biol Chem 1987;262:14891-14894.
14. von der Möhlen MAM, Kimmings AN, Wedel NI, et al. The effect of a recombinant bactericidal/permeability increasing protein on cytokine release in experimental endotoxemia in humans. J Infect Dis 1995;172:144-151.
15. Bode C, Fukui H, Bode JC. 'Hidden' endotoxin in plasma of patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 1993;5:257-262.
16. Dentener MA, Greve JW, Maessen JG, Buurman WA. Role of tumor necrosis factor in the phenomenon of the enhanced sensitivity of animals to endotoxin after exposure to lead. Immunopharmacol Immunotoxicol 1989;11:321-324.
17. Diamond T, Dolan S, Thompson RLE, Rowlands BJ. Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery 1990;108:370-378.
18. Greve JW, Gouma DJ, Soeters PB, Buurman WA. Suppression of cellular immunity in obstructive jaundice is caused by endotoxins. A study in germ-free rats. Gastroenterology 1990;98:478-485.
19. Boermeester MA, Houdijk AP, Meyer S, et al. Liver failure induces a systemic inflammatory response. Prevention by recombinant N-terminal bactericidal/permeability-increasing protein. Am J Pathol 1995;147:1428-1440.
20. Dentener MA, Francot GJM, Smit FT, et al. Presence of bactericidal/permeability increasing protein in disease; detection by ELISA. J Infect Dis 1995;171:739-743.
21. Opal SM, Palardy JE, Marra MN, et al. Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 1994;344:429-431.
22. Froon AHM, Dentener MA, Greve JW, et al. Lipopolysaccharide toxicity-regulating proteins in bacteremia. J Infect Dis 1995;171: 1250-1257.
23. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 1992;149: 200-206.
24. Kohn FR, Ammons WS, Horowitz A, et al. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability increasing protein in experimental endotoxemia. J Infect Dis 1993;168:1307-1310.
25. Kelly CJ, Cech AC, Argenteanu M, et al. Role of bactericidal/permeability increasing protein in the treatment of gram-negative pneumonia. Surgery 1993;114:140-146.